- Home
- OPRX
as 11-20-2025 3:36pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 380.6M | IPO Year: | N/A |
| Target Price: | $14.83 | AVG Volume (30 days): | 331.6K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.99 - $22.25 | Next Earning Date: | 11-06-2025 |
| Revenue: | $109,506,000 | Revenue Growth: | 24.18% |
| Revenue Growth (this year): | 17.92% | Revenue Growth (next year): | 10.91% |
Stock Insider Trading Activity of OptimizeRx Corporation (OPRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | OPRX | Chief Executive Officer | Oct 3 '25 | Sell | $18.75 | 1,620 | $30,375.00 | 188,916 | |
| Spangler Patrick D | OPRX | Director | Aug 28 '25 | Sell | $17.49 | 11,120 | $194,488.80 | 44,215 |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
Simply Wall St.
13 days ago
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts
GuruFocus.com
14 days ago
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ...
Zacks
14 days ago
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
GlobeNewswire
14 days ago
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
GuruFocus.com
15 days ago
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q3 2025 Result
Zacks
2 months ago
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
GlobeNewswire
2 months ago
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.